Telomir Pharmaceuticals Inc (TELO)

03:38 AM

Geode Capital Management LLC Has $1.71 Million Stock Holdings in Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) - Defense World

03:38 AM

Apr 28, 2025

TELO stock touches 52-week low at $2.35 amid market challenges - Investing.com

Apr 28, 2025

Apr 17, 2025

TELO stock touches 52-week low at $2.46 amid market challenges By Investing.com - Investing.com South Africa

Apr 17, 2025

Apr 17, 2025

TELO stock touches 52-week low at $2.46 amid market challenges - Investing.com

Apr 17, 2025

Apr 16, 2025

Corebridge Financial Inc. Has $40,000 Position in Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) - Defense World

Apr 16, 2025

Apr 09, 2025

Comparing Telomir Pharmaceuticals (TELO) and The Competition - Defense World

Apr 09, 2025

Apr 08, 2025

TELO stock touches 52-week low at $2.59 amid market challenges By Investing.com - Investing.com South Africa

Apr 08, 2025

Apr 08, 2025

TELO stock touches 52-week low at $2.59 amid market challenges - Investing.com

Apr 08, 2025

Apr 02, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 02, 2025

Apr 02, 2025

Charles Schwab Investment Management Inc. Boosts Position in Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) - Defense World

Apr 02, 2025

Apr 01, 2025

TELO stock touches 52-week low at $3.1 amid market challenges By Investing.com - Investing.com South Africa

Apr 01, 2025

Apr 01, 2025

TELO stock touches 52-week low at $3.1 amid market challenges - Investing.com

Apr 01, 2025

Apr 01, 2025

Virtu Financial LLC Acquires Shares of 14,959 Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) - Defense World

Apr 01, 2025

Mar 29, 2025

Bank of New York Mellon Corp Increases Stock Position in Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) - Defense World

Mar 29, 2025

Mar 25, 2025

Analyzing Telomir Pharmaceuticals (TELO) & The Competition - Defense World

Mar 25, 2025

Mar 23, 2025

Telomir Pharmaceuticals Announces Significant Anti-Cancer Effects in Prostate Cancer Animal Model Using Highly Aggressive Human Prostate Cancer Cells - Bluefield Daily Telegraph

Mar 23, 2025

Mar 21, 2025

Telomir Pharmaceuticals announces anti-cancer effects in prostate cancer animal model - MSN

Mar 21, 2025

Mar 19, 2025

SWK Holdings Announces Monetization of Royalty Portfolio - Waco Tribune-Herald

Mar 19, 2025

Mar 19, 2025

Telomir-1 shows promise in cancer and chemotherapy study By Investing.com - Investing.com South Africa

Mar 19, 2025

Mar 19, 2025

Telomir Pharmaceuticals Says Telomir-1 Reduces Tumor Size in Prostate Cancer Animal Model - MarketScreener

Mar 19, 2025

Mar 19, 2025

Telomir-1 shows promise in cancer and chemotherapy study - Investing.com

Mar 19, 2025

Mar 19, 2025

Telomir Pharmaceuticals reports breakthrough in prostate cancer treatment By Investing.com - Investing.com South Africa

Mar 19, 2025

Mar 19, 2025

Telomir Pharmaceuticals reports breakthrough in prostate cancer treatment - Investing.com India

Mar 19, 2025

Mar 19, 2025

Breakthrough: New Cancer Drug Cuts Prostate Tumors by Half While Reducing Chemo Toxicity - StockTitan

Mar 19, 2025

Mar 19, 2025

Telomir Pharmaceuticals Lead Drug Candidate Inhibits Tumor Growth In Aggressive Prostate Cancer Cells, Animal Study Shows - Benzinga

Mar 19, 2025

Mar 12, 2025

Rhumbline Advisers Boosts Position in Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) - Defense World

Mar 12, 2025

Mar 04, 2025

Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) Short Interest Up 34.4% in February - Defense World

Mar 04, 2025

Feb 26, 2025

Telomir-1 shows promise in reversing cell aging By Investing.com - Investing.com South Africa

Feb 26, 2025

Feb 26, 2025

Telomir-1 shows promise in reversing cell aging - Investing.com India

Feb 26, 2025

Feb 26, 2025

Telomir Pharmaceuticals Announces Breakthrough: Telomir-1 Reverses Calcium Dysregulation, the Hidden Driver of Aging and Disease, in Multiple Human Cell Lines - Eagle-Tribune

Feb 26, 2025

Feb 26, 2025

Could This Anti-Aging Compound Revolutionize Treatment for Alzheimer's and Macular Degeneration? - StockTitan

Feb 26, 2025

Feb 25, 2025

Telomir Pharmaceuticals announces Telomir-1 reverses calcium dysregulation in multiple human cell lines - MSN

Feb 25, 2025

Feb 25, 2025

Telomir Pharmaceuticals reports key preclinical success By Investing.com - Investing.com South Africa

Feb 25, 2025

Feb 25, 2025

Telomir Pharmaceuticals reports key preclinical success - Investing.com India

Feb 25, 2025

Feb 25, 2025

Telomir Pharmaceuticals achieves breakthrough in silver ion stabilization - MSN

Feb 25, 2025

Feb 24, 2025

Telomir Pharmaceuticals (NASDAQ:TELO) Research Coverage Started at Rodman & Renshaw - Defense World

Feb 24, 2025

Feb 23, 2025

Telomir-1 exhibited strong ROS reduction properties, hold potential for AMD treatment - Ophthalmology Times

Feb 23, 2025

Feb 21, 2025

Telomir reports stabilization of silver forms for medical use By Investing.com - Investing.com Nigeria

Feb 21, 2025

Feb 21, 2025

Telomir Pharmaceuticals Says Telomir-1 Compound Stabilizes Silver for Advanced Medical Applications - Marketscreener.com

Feb 21, 2025

Feb 21, 2025

Telomir reports stabilization of silver forms for medical use - Investing.com

Feb 21, 2025

Feb 21, 2025

Telomir Pharmaceuticals Achieves Breakthrough in Silver Ion Stabilization, Unlocking a Multi-Billion-Dollar Medical Market - Weatherford Democrat

Feb 21, 2025